Clinical trial finds RNA inhibitor effectively reduces 'bad cholesterol' in patients with cardiovascular disease
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Yahoo Finance5d
Information Services Group, Inc. (III)
After hours: February 14 at 5:21:36 PM EST Loading Chart for III ...